<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Palmitoyl Tetrapeptide-7: what changed | Grey Peptides</title>
    <link>https://greypeptides.com/changes/#e-palmitoyl-tetrapeptide-7</link>
    <atom:link href="https://greypeptides.com/changes/palmitoyl-tetrapeptide-7.xml" rel="self" type="application/rss+xml" />
    <description>News, regulatory alerts, corrections and new guides about Palmitoyl Tetrapeptide-7 on Grey Peptides, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 30 Oct 2026 12:00:00 +0000</lastBuildDate>
    <ttl>1440</ttl>
    <item>
      <title>Correction: Corrected: Palmitoyl tetrapeptide-7</title>
      <link>https://greypeptides.com/corrections/#c-q1013-pt7-alias</link>
      <guid isPermaLink="false">greypeptides-changes-palmitoyl-tetrapeptide-7-corr-c-q1013-pt7-alias</guid>
      <pubDate>Fri, 30 Oct 2026 12:00:00 +0000</pubDate>
      <category>Correction</category>
      <description>Aliases are Pal-GQPR, palmitoyl-GQPR, palmitoyl tetrapeptide-3 and Pal-Gly-Gln-Pro-Arg (PubChem lists tetrapeptide-3 as the same compound); the IL-6 claim is described as unsourced, and what it did alone (more type III collagen in UV-exposed fibroblasts) is cited.</description>
    </item>
  </channel>
</rss>
